Showing results (341-350 of 545) with videos related to
Sort By:
Pageof 55
Transplantation|May 13, 2022
High Oxygenation During Normothermic Regional Perfusion After Circulatory Death Is Beneficial on Donor Cardiac Function in a Porcine ModelNiels Moeslund, Zhang Long Zhang, Lars Bo Ilkjaer, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 14, 2023
Ex-situ oxygenated hypothermic machine perfusion in donation after circulatory death heart transplantation following either direct procurement or in-situ normothermic regional perfusionNiels Moeslund, Imran A Ertugrul, Michiel A Hu, et al.BMJ Open|December 13, 2019
Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxisAda Miltz, Fiona Lampe, Sheena McCormack, et al.The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.AIDS (London, England)|December 20, 2007
Survival following HIV infection of a cohort followed up from seroconversion in the UKFiona M Ewings, Krishnan Bhaskaran, Ken McLean, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohortsXiaojie Huang, Sara Lodi, Zoe Fox, et al.Ebiomedicine|October 27, 2015
During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQAlessandra Ruggiero, Ward De Spiegelaere, Alessandro Cozzi-Lepri, et al.Plos One|November 19, 2013
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infectionSara Lodi, Martin Fisher, Andrew Phillips, et al.AIDS (London, England)|March 22, 2008
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individualsBrian Angus, Fiona Lampe, Guiseppe Tambussi, et al.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|January 15, 2020
Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?Satyam Kumar, Ananth Srinivasan, Andrew Phillips, et al.Pageof 55